Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,063
Closed -$2.65M 604
2022
Q3
$2.65M Sell
6,063
-6,903
-53% -$3.32M 0.01% 398
2022
Q2
$6.09M Buy
12,966
+2,533
+24% +$1.24M 0.03% 213
2022
Q1
$5.29M Buy
10,433
+5,417
+108% +$2.6M 0.02% 248
2021
Q4
$2.65M Sell
5,016
-4,035
-45% -$1.94M 0.01% 292
2021
Q3
$4.21M Buy
9,051
+3,616
+67% +$1.7M 0.02% 247
2021
Q2
$2.58M Buy
+5,435
New +$2.61M 0.01% 313

Other funds holding CHE

Brookfield Corp's CHE Position: Q4 2022 in Review

Brookfield Corp sold out of Chemed (CHE) in Q4 2022, closing a stake of 6,063 shares — an estimated $2.65M sold.

Brookfield Corp first reported a position in CHE in Q2 2021 and held it in 6 quarters. The position peaked at $6.09M in Q2 2022. 442 funds tracked by Wall St. Rank hold CHE as of Q4 2022.

  • Brookfield Corp reported no remaining Chemed position as of Q4 2022 after selling out during the quarter.
  • Brookfield Corp sold 6,063 Chemed shares in Q4 2022, an estimated $2.65M.
  • Brookfield Corp first reported a position in Chemed in Q2 2021 and held it in 6 quarters.
  • Brookfield Corp's Chemed position peaked at $6.09M in Q2 2022.
  • 442 funds tracked by Wall St. Rank held Chemed as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.